VOYG•businesswire•
Voyager Enables Microgravity-Enabled Drug Discovery
Summary
DENVER--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) announced a new contract with Space LiinTech to manifest a new payload to the International Space Station, advancing microgravity-enabled drug discovery. “The most important breakthroughs in space-enabled medicine will come from consistent, high-fidelity access to orbit,” said Matt Magaña, president, Space, Defense & National Security at Voyager. “Microgravity changes crystallization, growth dynamics and material properties at a fun
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 22, 2026 by businesswire